SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as traders debate the company's upcoming maintenance data for VK2735, with sentiment split between optimism over potential best-in-class efficacy and frustration regarding the CEO's communication style and lack of updates. While some investors view the current price as a buying opportunity ahead of clinical catalysts and potential M&A interest, others remain skeptical, citing past price declines and concerns over the timing of results.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

Investors are expressing significant frustration over QXO's persistent downward price action, which many attribute to excessive dilution and unfavorable macroeconomic conditions, such as high interest rates and housing market headwinds. While some traders are betting on long-term value and potential mean reversion, others remain skeptical, pointing to the lack of clear catalysts and the CEO's perceived silence amid the stock's poor performance.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is facing downward pressure following reports of a fatal cargo plane crash involving a Boeing 767 contracted through its Amazon Air network. While investors are weighing the potential liability and operational risks, traders remain focused on the company's broader AI and cloud infrastructure growth plans.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the release of positive final Phase 3 ORIGIN 3 trial results for its drug, Trutakna, which demonstrated a 76% reduction in the risk of kidney disease progression. The community is focused on the company's plan to submit a supplemental biologics license application for full FDA approval in late 2026, with some traders debating the competitive landscape and potential for M&A activity.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon is experiencing significant volatility following its recent announcement of a $1 billion convertible senior notes offering, with traders debating whether the raise provides growth capital or signals future dilution. The stock's sharp decline has triggered frustration among retail investors, who are contrasting the financing move against ongoing concerns over insider selling and valuation multiples.

Dave & Buster's Entertainment, Inc. engages in the ownership and operation of entertainment and dining venues under the name Dave & Buster's. It offers a full menu of entrées and appetizers, a selection of alcoholic and non-alcoholic beverages, and an assortment of entertainment attractions centered around playing games and watching live sports and other televised events. The company was founded by David O. Corriveau and James W. Corley in 1982 and is headquartered in Coppell, TX.

Dave & Buster`s Entertainment Inc

Dave & Buster's Entertainment

Dave & Buster's shares dropped significantly after the company reported a surprise second-quarter loss and missed revenue expectations. While the community remains divided, many traders highlight skepticism over the company's turnaround efforts and debt levels, even as some retail sentiment remains optimistic regarding management's long-term strategy.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending following a strong quarterly earnings report that highlighted record bookings, a substantial $3 billion backlog, and aggressive growth guidance through fiscal 2027. While some investors are optimistic about the company's role in supporting AI data center infrastructure, others are expressing concern regarding low cash reserves and potential volatility from share offerings.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Traders are intensely focused on the escalating conflict in the Middle East, specifically highlighting the shutdown of a critical Saudi Arabian oil pipeline and Houthi-led maritime attacks as key drivers for the sustained rally in oil prices. While some market participants anticipate continued upside momentum due to supply constraints, others express skepticism and monitor for potential volatility driven by government diplomatic efforts and geopolitical rumors.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals shares are facing volatility as traders debate the company's long-term pipeline potential and commercial prospects following the recent REDEMPLO launch, while expressing frustration with perceived market-maker manipulation. Despite positive Phase 3 SHASTA-3 and SHASTA-4 data, the stock has traded within a range as investors wait for further clinical readouts and potential M&A activity.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is seeing significant attention centered on anticipation for upcoming clinical trial data presentations and continued buyout speculation. While some investors are optimistic about the company's path to profitability and its pipeline potential, others express frustration with recent price volatility and perceived institutional manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ITRI scaling in here for the next 12-18 months

AmmyHour

StockTwits for iOS

Itron Inc.

 scaling in here for the next 12-18 months

@AmmyHour a debt is bit high but super safe and manageable, also scaled into Xylem

 a debt is bit high but super safe and manageable, also scaled into Xylem